Contemporary Diagnosis, Management, and Outcomes of Patients With Low-Gradient Severe Aortic Stenosis: A Multi-Center Analysis

BACKGROUND

The American College of Cardiology/American Heart Association guidelines recommend assessing aortic stenosis (AS) using American Society of Echocardiography-endorsed parameters and referring patients with severe symptomatic AS for treatment. Yet, multi-site real-world assessment of guideline adherence is lacking.

METHODS

We assessed consecutive echocardiographic reports for patients >18 years of age from 30 US institutions with appropriate permissions between January 2018–March 2024 (egnite Database; egnite, Inc.). Completeness of echocardiographic evaluation of AS was assessed. Patients with severe AS were stratified into high- and low-gradient (HG, mean aortic gradient [MG] ≥40 mm Hg; LG, MG <40 mm Hg). Rates of Heart Team evaluation within 60 days and aortic valve replacement (AVR) within 6 months were assessed via the Kaplan-Meier method.

RESULTS

Of 2,829,095 echocardiographic reports, Vmax, MG, aortic valve area (AVA), stroke volume index, left ventricular ejection fraction (LVEF), and AS severity were missing in 25%, 30%, 35%, 83%, 5%, and 36%, respectively. Of 1,189,382 patients with available AS severity assessment, 45,967 had an AVA ≤1.0 cm2 and/or Vmax≥4.0 m/s with only 52% being diagnosed with severe AS and 20% being diagnosed as <moderate AS. Of 26,903 patients (2.3%) diagnosed with severe AS, there was a greater proportion of LG cases (LG: 52%, HG: 48%). Regardless of LVEF or symptoms, a lower proportion of severe LG AS patients were evaluated by a Heart Team within 60 days (LG: 37%, HG: 53%) and received an AVR within 6 months (LG: 35%, HG: 61%). Patients not evaluated by the Heart Team were older and more likely to be female and non-White than those who were evaluated, despite a comparable history of heart failure. A greater number of mortality events was observed among LG vs HG patients seen (877/10,241 vs. 381/9304) and not seen (2679/10,121 vs. 914 / 3453) by the Heart Team.

CONCLUSIONS

Key parameters needed to diagnose the severity of AS are often missing in echocardiographic reports. Compared to HG, severe LG AS patients have lower Heart Team evaluation rates, with racial, sex, and age disparities, as well as lower AVR rates and more observed mortality events. Further work is needed to enhance guideline adherence for the diagnosis and management of patients with severe LG AS.

Vemulapalli S, et al. Contemporary diagnosis, management, and outcomes of patients with low-gradient severe aortic stenosis: a multi-center analysis [abstract 4147314]. Circulation. 2024;150(suppl 1):4147314. doi:10.1161/circ.150.suppl_1.4147314. (AHA Scientific Sessions 2024.)

*This study is part of egnite’s cardiovascular real-world evidence bibliography, which lists all of our peer-reviewed articles, conference abstracts, and patents.

Follow egnite on social:

Related Articles

Press

egnite’s Call for Science Study on M-TEER Device Durability and Long-Term Patient Outcomes to be Featured at TCT 2026

The egnite Registry contributed de-identified, longitudinal data, linking serial echocardiograms with clinical outcomes, to help answer what happens to patients after a successful mitral transcatheter edge-to-edge repair (M-TEER) procedure.  ALISO VIEJO, Calif. — October 13, 2026 — egnite, Inc., a cardiovascular intelligence company that helps clinicians identify and manage patients with untreated heart disease, today announced that Dr. John T. Saxon, Director of the Advanced Cardiac Valve Center at University of Virginia

Publications

Mitral Regurgitation and Severe Aortic Stenosis: Clinical Characteristics, Prognostic Impact, and Response to TAVR: Insights From egnite Data

BACKGROUND Aortic stenosis (AS) and mitral regurgitation (MR) frequently co-occur, complicating diagnosis and treatment. We examined current US treatment trends and patient outcomes among patients with severe AS and at least moderate MR. METHODS We analyzed data from 2 992 362 patients (aged ≥18 years) undergoing 5 245 904 echocardiograms at 43 US institutions

"The future of aortic stenosis care requires proactive identification, longitudinal monitoring, and intentional pipeline management."
egnite Research

Rethinking the Aortic Stenosis Pipeline

Aortic stenosis care is shifting from a reactive to a proactive model. Emerging clinical evidence supports earlier identification, closer monitoring, and intentional patient management across the disease continuum. As treatment thresholds evolve, health systems need scalable approaches to identify at-risk patients, close treatment gaps, and ensure timely access to specialist care.